Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Takeda Opens New Global Research Center in San Diego | Contract Pharma

What are you searching for?

Sign in
Breaking News

Takeda Opens New Global Research Center in San Diego

New facility focuses on specialized drug discovery technologies and discovery research across gastrointestinal and neuroscience therapeutic areas

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Takeda has opened a new research facility in San Diego, CA. The 165,000-square-foot facility is home to more than 250 employees focused on leveraging specialized drug discovery technologies and advancing discovery research in gastroenterology and neuroscience.
 
The facility is home to four research platform groups—structural biology, early target discovery, computational biology and biologics—that provide key capabilities to discover and advance promising molecules. The new research center in San Diego complements Takeda’s global Research & Development center in Cambridge, MA and its other global research site in Shonan, Japan.
 
“Our San Diego research center demonstrates an ideal balance between highly specialized internal research competencies and dedication to external partnerships both within the local community and on a global scale,” said Steve Hitchcock, head of research, Takeda. “By consulting with and leveraging our relationships with academic and industry partners and patient groups, we are able to operate nimbly and efficiently to advance early discovery research that could potentially translate into transformative, life-changing therapies for patients in need, complementing our efforts in our other global research centers in Cambridge and Shonan.”
 
Takeda’s R&D efforts are in four therapeutic areas—oncology, gastroenterology (GI), neuroscience and rare diseases—with targeted investments also committed to plasma-derived therapies (PDT) and vaccines. More than 50 percent of Takeda’s research pipeline focuses on non-small molecules, including biologics, peptides, oligonucleotides, cell and gene therapy, the microbiome and other modalities.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics